TRENDS
Biocon Biologics, Sandoz sign pact to distribute adalimumab biosimilar Humira in Japan
Adalimumab BS for subcutaneous injection is a biosimilar of Humira, offering therapeutic solutions for immune-related diseases such as rheumatoid arthritis, psoriasis vulgaris, ankylosing spondylitis, Crohn's disease and ulcerative colitis
TRENDS
Serum Institute eyes approval for XBB1 variant vaccine to tackle COVID-19 JN.1 strain
India reported 1,394 active cases of Covid-19 on December22, 5 am, according to the data provided by the Ministry of Health and Family Welfare
BUSINESS
Centre proposes to decriminalise medical negligence in amended criminal law bill
Union Home Minister Amit Shah informed of an amendment in the criminal law bill, which will exempt doctors from criminal prosecution in cases of death due to medical negligence
BUSINESS
Drug regulator issues warning against cold medication for children under 4 yrs
The the Subject Expert Committee of the Central Drugs Standard Control Organisation recommended a precautionary measure, suggesting that the FDC should not be administered to children below 4 years
BUSINESS
Sun Pharma to acquire 16.7% in Lyndra Therapeutics for $30 million
The US company had a turnover of $10.7 million in 2022.
BUSINESS
Jefferies picks Indian hospitals as top growth sector for FY24-26 amidst anticipated capacity surge
The sector will be characterised by sharp bursts of growth and periods of slow growth but will see a big capacity expansion and rise in average revenue per occupied bed.
BUSINESS
Cipla raises stake in digital tech company GoApptiv
With the completion of this deal, Cipla’s total stake in GoApptiv will increase to 22.99% on a fully diluted basis
BUSINESS
Indian hospitals thrive post-Covid, driven by strong financial growth, expansion
Larger hospital companies also explored inorganic growth opportunities, bolstering investor interest
BUSINESS
Life insurance premium collections fall 25% in November
Life insurers have managed to collect a total premium of Rs 26494.83 crore in November and Rs 2,11,690.65 crore so far in FY24.
BUSINESS
Dr Reddy’s signs pact with Coya for investigational therapy of ALS
Dr. Reddy’s will make a $7.5 million upfront payment to Coya. Under the terms of the agreement, Coya has granted Dr Reddy’s an exclusive license to commercialise COYA 302
BUSINESS
Himadri plans to set up Rs 4,800 crore LFP cathode manufacturing plant in Odisha
The company plans to fund the new project primarily from internal accruals.
BUSINESS
US FDA hits Intas Pharma with warning letter; notes data integrity lapses at Ahmedabad plant
The regulator noted that visual inspectors manipulated particle and other defect counts on records to keep the finished product batches within rejection limits
BUSINESS
Glenmark, Sun Pharma recall drugs in the US over labelling and manufacturing concerns, confirms USFDA
Glenmark Pharmaceuticals recalled 37,200 bottles of Indomethacin capsules and Sun Pharma recalled 2016 bottles of buPROPion Hydrochloride Extended-Release Tablets.
BUSINESS
Biocon bets big on new class of weight-loss drugs
Company aims to ramp up portfolio as key drugs—that were actually formulated to treat diabetes—go off patent
TRENDS
Healthcare space leads in advertising violations, says ASCI report
While the ASCI accepts complaints from various sources, 21.3 percent were consumer complaints, indicating substantial public involvement in upholding advertising standards. Suo-motu complaints by ASCI constituted 75.4 percent of the total.
BUSINESS
Dr Reddy’s rolls out wearable migraine management device in India
Nerivio is a drug-free wearable and intended for acute and prophylactic (preventive) migraine in patients aged 12 years and above
TRENDS
Health Ministry releases National Pharmacy Commission Bill to replace Pharmacy Council
The Bill is expected to reinvigorate pharmacy education and raise its standard. Pharmacy education has remained stagnant for the last many years. The new commission will regulate and evaluate professionals in the field
BUSINESS
JB Pharma’s Lozenge Leap: From cough candy to heart health and beyond
The company aims to diversify into lozenges for sleep disorders, anti-inflammatory lozenges, and immunity-boosting lozenges. It also plans to improve its presence in the cardiovascular segment.
BUSINESS
Brokerages positive on Alembic Pharma's US growth outlook, weak domestic show still a concern
They expect the company’s forthcoming facility launches in the US to lead to a healthy operating leverage. Alembic Pharma plans to launch over 20 products in FY24, with a focus on oral solids, injectables, and derma segments
BUSINESS
Lupin and Amman Pharma sign licensing agreement for Ranibizumab biosimilar
Ranibizumab is used in the treatment of various age related eye conditions.
BUSINESS
Metropolis Healthcare to spend Rs 50-55 crore over two years to expand
The company has positioned itself as a premium diagnostics player. The premium wellness category was its fastest-growing segment in Q2
BUSINESS
Indian diagnostic sector set for double-digit growth in medium term: CareEdge Ratings
After Covid-19, India's approach to healthcare has shifted towards prevention and this is benefitting diagnostic companies
BUSINESS
Brokerages maintain cautious stance on Dr. Lal PathLabs post Q2 recovery
The diagnostics player reported a 52.4 percent year-on-year rise in consolidated net profit at Rs 109.3 crore for the July-September quarter of the current financial year
BUSINESS
Indian pharma, healthcare deals value jumps 298% YoY in July-September: Grant Thornton
The biggest deal in the period was Nirma’s acquisition of Glenmark Lifesciences for $689 million
